Modeling lesion counts in multiple sclerosis when patients have been selected for baseline activity

The number of new gadolinium-enhancing lesions discovered via magnetic resonance imaging is a well-established outcome for multiple sclerosis studies, especially Phase II Studies. Due to the high cost of magnetic resonance imaging scans, many investigators select participants for the presence of lesions. While this selection procedure is thought to improve the power of inferences, the effect of screening for baseline activity on parameter estimation and interval coverage has not yet been examined. The objective of this study was to investigate the performance of the negative binomial distribution for modeling lesion count data in multiple sclerosis when patients have been selected for activity on a baseline scan. We performed computer simulations to investigate the influence of the screening process on inferences made using a negative binomial model about treatment effects in two independent samples. We also demonstrate how the statistical properties of screening can be incorporated into trial design. We demonstrate that when the negative binomial distribution is used to model lesion counts, while screening for baseline activity improves point estimation, this practice also has the potential to decrease interval coverage and inflate the Type I error rate. For data that is to be modeled using a negative binomial distribution, screening for baseline activity can create a trade-off between cost effectiveness and a higher than desired false positive rate that must be carefully considered in planning Phase II trials.

[1]  M. Filippi,et al.  Statistical Issues Related to the Use of MRI Data in Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[2]  F. Barkhof,et al.  Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results , 1999, Journal of neurology, neurosurgery, and psychiatry.

[3]  Robert J. Temple,et al.  Special study designs: early escape, enrichment, studies in non-responders , 1994 .

[4]  G. Comi,et al.  Modelling new enhancing MRI lesion counts in multiple sclerosis , 2001, Multiple sclerosis.

[5]  M. Filippi,et al.  The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis , 2005, Multiple sclerosis.

[6]  A. Thompson,et al.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: Statistical power of parallel-groups and crossover designs , 1994, Journal of the Neurological Sciences.

[7]  H. Akaike A new look at the statistical model identification , 1974 .

[8]  F. Barkhof,et al.  Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials , 1999, Journal of the Neurological Sciences.

[9]  C. Granger,et al.  Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis , 1996, Annals of neurology.

[10]  Roland Martin,et al.  Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis , 1992, Annals of neurology.

[11]  G Cutter,et al.  Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS , 2001, Neurology.

[12]  Massimo Filippi,et al.  European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis , 2001, Annals of neurology.

[13]  F. Barkhof,et al.  Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets , 2001, Journal of neurology, neurosurgery, and psychiatry.

[14]  A. Thompson,et al.  The distribution of magnetic resonance imaging response to interferonβ–1b in multiple sclerosis , 2005, Journal of Neurology.

[15]  F Barkhof,et al.  The distribution of new enhancing lesion counts in multiple sclerosis: further explorations , 2009, Multiple sclerosis.

[16]  Inmaculada B. Aban,et al.  Inferences and power analysis concerning two negative binomial distributions with an application to MRI lesion counts data , 2009, Comput. Stat. Data Anal..